In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG.
Publication
, Journal Article
Carnicelli, AP; Granger, CB
Published in: Ann Intern Med
January 21, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
January 21, 2020
Volume
172
Issue
2
Start / End Page
JC3
Location
United States
Related Subject Headings
- Humans
- General & Internal Medicine
- Dyslipidemias
- Coronary Artery Bypass
- Cardiovascular Diseases
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Carnicelli, A. P., & Granger, C. B. (2020). In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG. Ann Intern Med, 172(2), JC3. https://doi.org/10.7326/ACPJ202001210-003
Carnicelli, Anthony P., and Christopher B. Granger. “In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG.” Ann Intern Med 172, no. 2 (January 21, 2020): JC3. https://doi.org/10.7326/ACPJ202001210-003.
Carnicelli AP, Granger CB. In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG. Ann Intern Med. 2020 Jan 21;172(2):JC3.
Carnicelli, Anthony P., and Christopher B. Granger. “In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG.” Ann Intern Med, vol. 172, no. 2, Jan. 2020, p. JC3. Pubmed, doi:10.7326/ACPJ202001210-003.
Carnicelli AP, Granger CB. In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG. Ann Intern Med. 2020 Jan 21;172(2):JC3.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
January 21, 2020
Volume
172
Issue
2
Start / End Page
JC3
Location
United States
Related Subject Headings
- Humans
- General & Internal Medicine
- Dyslipidemias
- Coronary Artery Bypass
- Cardiovascular Diseases
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
- 3202 Clinical sciences
- 11 Medical and Health Sciences